Introduction
============

Tracheostomy, an ancient surgical procedure originally described in the first century BC \[[@B1]\], is one of the more commonly performed procedures in modern intensive care, and is predicted to become more common as demand for intensive care services increases \[[@B2],[@B3]\]. While the benefits of early tracheostomy for patients who require extended periods of mechanical ventilation, compared to prolonged translaryngeal intubation, have been recently debated \[[@B4]-[@B6]\], the optimal method of performing tracheostomies in critically ill patients remains unclear.

The traditional method of performing tracheostomies in critically ill patients requires transport from the intensive care unit (ICU) to the operating theatre (OT), where a surgical team performs an open or surgical tracheostomy (ST). This involves a full dissection of the pretracheal tissues and insertion of the tracheostomy tube into the trachea under direct vision \[[@B7]\]. Percutaneous dilatational tracheostomy (PDT) was first described in 1957 \[[@B8]\], and became increasingly popular after the release of a commercially available kit in 1985 \[[@B9]\]. This technique involves the use of blunt dilatation to open the pretracheal tissue for passage of the tracheostomy tube. Proponents of PDT suggest that the limited dissection results in less tissue damage, lowers the risk of bleeding and wound infection, and is able to be performed at the bedside in the ICU, which may overcome the risks associated with transport of critically ill patients to the OT \[[@B10]\].

The proportion of patients receiving PDT and ST varies greatly in different practice settings, with ST being performed exclusively in some ICUs, PDT being performed almost exclusively in others and others using a mixture of both techniques \[[@B11]-[@B14]\]. Three previous meta-analyses have attempted to resolve which method of performing tracheostomies is superior; however, results from these reviews are limited for several reasons. One included both randomized and non-randomized studies \[[@B15]\]. The other two meta-analyses included only four \[[@B16]\] and five \[[@B17]\] randomized trials, respectively, made no attempt to find unpublished studies, made no assessment of the possible impact of publication bias, nor explicitly assessed the validity of those trials included. Current guidelines would suggest that meta-analyses lacking these features may arrive at unreliable conclusions \[[@B18]\]. As such, the question of whether PDT or ST is superior for critically ill patients remains unanswered.

To address these shortcomings and provide a comprehensive and contemporary overview, we performed a systematic review and meta-analysis to investigate whether, for adult critically ill patients who require an elective tracheostomy, PDT is superior to ST with regards to the incidence of wound infection, bleeding, and overall mortality as well as major peri-operative complications. We also examined whether one technique was associated with improved rates of longer-term complications.

Materials and methods
=====================

Search strategy
---------------

Randomized clinical trials (RCTs) comparing PDT with ST in critically ill patients were identified using both electronic and manual search strategies supplemented by scanning the bibliographies of all retrieved articles as well as review articles, and reviewing selected conference proceedings (American Thoracic Society (2001 to 2005), Society of Critical Care Medicine (2001 to 2005), European Society of Intensive Care Medicine (2001 to 2005) and American College of Chest Physicians (2002 to 2005)). In addition, we searched for unpublished studies by contacting the manufacturers of two percutaneous tracheostomy kits (Cook^®^Group Inc, Bloomington, IN, USA) and Smiths Medical (Portex^®^), London, UK), and by contacting experts in the field. All languages were considered eligible. The electronic literature search was completed on December 31, 2005.

MEDLINE (inception to 2005), EMBASE (inception to 2005), CINAHL (inception to 2005) and the Cochrane Controlled Clinical Trials Register databases (inception to 2005) were searched via OVID. MEDLINE (inception to 2005) was also search using the Pubmed interface. Three comprehensive search themes were combined using the Boolean operator \'AND\'. The first theme used highly sensitive RCT filters \[[@B19],[@B20]\]. The second theme was created using exploded medical subject headings (MeSH) and textword search for \'tracheostomy\' or \'tracheotomy\'. The third theme, critical illness, was created by using the Boolean search term \'OR\' to search for the following terms appearing as both exploded MeSH and text words: \'critical care\' or \'critical illness\' or \'intensive care\' or \'critically ill\'.

Study selection
---------------

An initial screen of all titles and abstracts was conducted to confirm the report was of a trial comparing methods of performing tracheostomies in critically ill patients. The full text articles were retrieved and assessed to determine if they fulfilled the predetermined eligibility criteria for inclusion. Two authors (MN and SB) independently applied the inclusion criteria to the potentially eligible articles, with disagreements resolved by discussion or by resort to a third reviewer (AD). When data were not reported in sufficient detail to determine a studies\' eligibility, validity or outcomes, we attempted to contact the corresponding author by email for clarification. The report of one RCT \[[@B21]\] was translated from Korean into English prior to assessment. To be eligible for inclusion the article had to describe a study that fulfilled all of the following criteria: study design -- a RCT; intervention -- compared any method of elective PDT to ST; population -- included critically ill adults; and outcomes -- reported at least one of the measures bleeding, wound infection, mortality, duration of mechanical ventilation or ICU length of stay.

Validity assessment
-------------------

The validity of the included studies was assessed using *a priori*defined criteria. Each study was assessed for the adequacy of allocation concealment, blinding of outcome assessment, whether the analysis was conducted on an intention-to-treat basis, whether the outcomes were prospectively defined, and whether there were important differences between the two groups at baseline. When details of the allocation concealment were not specified in the article or could not be clarified by contact with the study authors, it was assessed as absent \[[@B22]\]. Blinding was deemed to be present when there was a description for a method of blinded assessment of any of the primary outcomes for that study. Again, two authors (SB and AD) independently assessed the validity of the studies with disagreement resolved by discussion.

Data abstraction
----------------

Data were abstracted onto standardized data collection forms by two authors (SB and AD), independently, with disagreements resolved by discussion. Data were collected regarding patient characteristics, the method of PDT used, the experience of the operators (whether the procedure was performed by a trainee or by an attending/consultant), the location where tracheostomies were performed (ICU or OT), whether the PDTs were performed under bronchoscopic guidance, and the duration of translaryngeal intubation prior to tracheostomy. STs were adjudicated to have been performed in the OT when any of the participants were transferred to the OT to have the procedure performed. Outcome data were collected, including the incidence of bleeding, wound infection, mortality and other major complications of the procedures. When available, data on the duration of mechanical ventilation and duration of ICU stay were recorded. We attempted to include only clinically important outcomes in our analysis. Wound infection was defined variably in the primary RCTs (as shown in Additional file 1), so for our analysis, when possible, only cases that prompted the administration of systemic antibiotics were included as wound infection. Bleeding was defined as bleeding that required an intervention, such as need for blood transfusion or surgical hemostasis, rather than bleeding that resolved spontaneously or with simple pressure. Other major complications were defined as those that were potentially life threatening or required an intervention and included loss of the airway, tube malplacement or pneumothorax. Mortality was defined as all-cause mortality for the longest period of follow-up reported in the study or until hospital discharge. Data were collected on long-term complications when available, including incidence of airway symptoms, delayed closure of fistula, tracheal stenosis, tracheal malacia, and characteristics of the scar.

Quantitative data synthesis
---------------------------

Agreement on the inclusion of studies was assessed with the Kappa statistic. Statistical heterogeneity was assessed using the χ^2^and *I*^2^statistics, with an *I*^2^value of \>50% indicating at least moderate heterogeneity \[[@B23]\]. When no statistical heterogeneity was evident, dichotomous data from selected RCTs were combined using the Mantel and Haenszel method to produce an estimate of the pooled odds ratio (OR) with 95% confidence intervals (CIs). Continuous outcomes were pooled using standardized mean differences (SMDs). The potential for publication bias was assessed by inspection of funnel plots for asymmetry and an Egger\'s test \[[@B24]\]. *A priori*selected subgroups for sensitivity analysis included two study quality factors (allocation concealment and blinding of outcomes), the method used to perform the PDT, the location where the tracheostomy was performed, and use of bronchoscopic guidance to guide the PDT. All statistical analyses were conducted using STATA 8.2 (StataCorp, College Station, TX, USA).

Results
=======

Study selection
---------------

Database searches generated a total of 1,482 references. There were 34 full text articles retrieved for review with 17 \[[@B21],[@B25]-[@B38]\] RCTs fulfilling all eligibility criteria for inclusion in the systematic review. While 16 of the studies were identified by the electronic search strategy, a single study of a recently completed RCT was identified by contact with an expert \[[@B39]\]. In addition, one study was published in abstract form only; however, the authors were contacted and provided complete details of the study, which enabled a thorough review and abstraction of relevant data\[[@B35]\] Agreement on the inclusion studies was 97% (kappa 0.93, *p*\< 0.0001). The flow of studies and reasons for exclusion are displayed in Figure [1](#F1){ref-type="fig"}.

Study description
-----------------

A total of 1,212 participants were randomized in the 17 RCTs. The study characteristics are shown in Table [1](#T1){ref-type="table"}. The majority (71%) of PDTs used a multiple dilator technique and 94% were performed in the ICU. A summary of the validity assessment for the 17 RCTs is displayed in Table [2](#T2){ref-type="table"}. Most studies had balanced groups at baseline and performed their analysis on an intention-to-treat basis; however, only two RCTs used methods to blind the adjudication of outcomes while only seven RCTs clearly maintained allocation concealment. No study had a loss to follow-up of \> 5% for the short-term outcomes; however, when longer term outcomes were reported, losses to follow-up were understandably significant, as displayed in Table [3](#T3){ref-type="table"}.

Evidence synthesis
------------------

### Wound infection

Clinically important wound infection was diagnosed in 6.6% (*n*= 57/870) of patients based on data from 11 RCTs \[[@B25],[@B26],[@B28]-[@B30],[@B32],[@B33],[@B36],[@B38]-[@B40]\] (Figure [2](#F2){ref-type="fig"}). There was a significant reduction in the OR for wound infection when the tracheostomy was performed using the PDT compared with the ST technique (OR = 0.28; 95% CI, 0.16 to 0.49, *p*\< 0.0005). There was no evidence of statistical heterogeneity across studies (χ^2^*p*= 0.43, *I*^2^= 1.0%) or evidence of bias on inspection of the funnel plot (Additional file 2) or with Eggers test (*p*= 0.18).

### Bleeding

The overall incidence of clinically relevant bleeding was 5.7% (*n*= 49/861) based on data available from 10 RCTs \[[@B25],[@B27],[@B28],[@B30]-[@B32],[@B37]-[@B40]\] (Figure [3](#F3){ref-type="fig"}). There was no significant difference in incidence when comparing PDT to ST (OR = 0.80; 95% CI, 0.45 to 1.41, *p*= 0.35). There was no evidence of significant statistical heterogeneity across studies (χ^2^*p*= 0.35, *I*^2^= 9.6%) or evidence of bias on inspection of the funnel plot (Additional file 3) or with Egger\'s test (*p*= 0.14).

### Mortality

The overall mortality rate was 37% (*n*= 339/914) based upon data available from 12 RCTs \[[@B25]-[@B30],[@B33]-[@B35],[@B38],[@B39]\]. There was no statistically significant difference in mortality for PDT compared with ST (OR = 0.79; 95% CI, 0.59 to 1.07, *p*= 0.13) (Figure [4](#F4){ref-type="fig"}). There was no evidence of statistical heterogeneity across studies (χ^2^*p*= 0.58, *I*^2^= 0%) nor evidence of bias by either funnel plot asymmetry (Additional file 4) or Egger\'s test (*p*= 0.56).

### Other short-term outcomes

Other major complications occurred in 2.6% (*n*= 15/574) of patients based on data available from 8 RCTs \[[@B26],[@B28],[@B30],[@B32],[@B34],[@B37],[@B39],[@B40]\]. There was no significant difference in the incidence of these major complications between those randomized to PDT or ST (OR = 1.3; 95% CI, 0.50 to 3.42, *p*= 0.59) (Additional file 5). There was no evidence of statistical heterogeneity across studies (χ^2^*p*= 0.95, *I*^2^= 0%).

The duration of translaryngeal intubation prior to tracheostomy was reported in 15 RCTs \[[@B21],[@B25]-[@B31],[@B33]-[@B39]\]. There was no difference in the duration of translaryngeal intubation prior to tracheostomy for patients receiving PDT as opposed to ST (Additional file 6). The pooled estimate of the SMD was -0.08 days (95% CI, -0.28 to 0.04, *p*= 0.19). There was no evidence of significant statistical heterogeneity across studies (χ^2^*p*= 0.30, *I*^2^= 13.4%). The total duration of mechanical ventilation and total ICU length of stay were not sufficiently reported to allow pooling of these results.

Effect of study quality on major outcomes
-----------------------------------------

Only two RCTs attempted to perform blinding for the adjudication of the presence of wound infection. Therefore, the presence of methods to maintain allocation concealment was the only study quality factor used to assess for influence on the pooled effect estimate. The pooled ORs for wound infection, bleeding and mortality from RCTs where allocation concealment was maintained were not significantly different from the ORs from the RCTs when allocation concealment was not maintained. The results of these analyses are further detailed in Table [4](#T4){ref-type="table"}.

Subgroup analysis
-----------------

The studies in which the ST was performed in the OT were pooled separately from those where ST was performed in the ICU. There was a significant reduction in the incidence of bleeding with the PDT technique compared to ST, when the STs were performed in the OT (OR = 0.29; 95% CI, 0.12 to 0.75, *p*= 0.01). Interestingly, there was a significant reduction in mortality with the PDT technique, compared to ST, when ST was performed in the OT (OR = 0.71; 95% CI, 0.50 to 1.0, *p*= 0.05). There was a trend toward a shorter duration of translaryngeal intubation prior to tracheostomy with PDT compared with ST, when the ST were performed in the OT (SMD = -0.15; 95% CI, -0.31 to 0.02, *p*= 0.08). Details of the subgroup analyses are shown in Table [4](#T4){ref-type="table"}. The method of PDT used and use of the bronchoscope to guide the placement of the PDT did not significantly affect the pooled effect estimates for wound infection, bleeding or mortality.

Long-term outcomes
------------------

Long-term complications for either tracheostomy technique were reported in eight RCTs and are presented in Table [3](#T3){ref-type="table"}\[[@B25],[@B29]-[@B31],[@B33],[@B35],[@B38],[@B39]\]. Delayed closure of the stoma, airway symptoms, tracheal stenosis and aesthetics of the scar were the most frequently reported complications; however, due to low rates of long-term follow-up, it is difficult to draw definitive inferences from these studies.

Discussion
==========

This systematic review and meta-analysis has demonstrated that the technique of PDT has a number of important advantages over performing a ST in critically ill patients who require an elective tracheostomy. First, PDT was associated with a reduction in the incidence of clinically important wound infections compared with traditional ST. Secondly, and importantly, there was no evidence overall that PDT resulted in an increased incidence of clinically significant bleeding, major peri-procedural or long term complications. Finally, results of subgroup analysis suggested that PDT was superior to ST when the latter was performed in the OT; specifically, PDT was associated with a reduction in bleeding and overall mortality and a suggestion of decreased duration of translaryngeal intubation prior to tracheostomy.

It is not surprising that a reduced incidence of wound infection was found with the PDT technique. One of the reasons that minimally invasive surgical techniques have become more pervasive in many areas of surgery is the reduction in the rates of surgical site infections \[[@B41]\]. This may be due to minimization of the local tissue damage with a dilatational technique, or may in part be due to a relative preservation of immune functions when minimally invasive techniques are used when compared to an open technique \[[@B42]\].

While there was no statistically significant reduction in mortality with either technique, a possible trend towards lower mortality with use of PDT warrants further discussion. One plausible explanation for this observation could relate to the reduced incidence of infection in those receiving PDT. One study reported the death of a patient who had a ST that could be directly attributable to a local wound infection \[[@B28]\]. The ability to perform the PDT in the ICU without exposing patients to the risks of transport could contribute as well \[[@B43],[@B44]\]. This contention would be supported by the reduction in mortality with PDT when compared to ST performed in the OT. However, this finding is inconclusive and before a change in clinical practice could be recommended, this would need confirmation in a larger, adequately powered multi-center randomized clinical trial.

While subgroup analyses require cautious interpretation in general, the subgroup analysis in this systematic review provides some supportive evidence for the advantages of PDT over ST, in particular when the STs were performed in the OT. One considerable advantage of PDT is the relative safety and convenience of performing the procedure at the bedside in the ICU, which obviates the need to transport a critically ill patient. The transport of critically ill patients is often logistically difficult and exposes the patient to increased likelihood for adverse events and risk to safety \[[@B43]-[@B46]\]. The results of our analysis would support the assertion that the elective transport of critically ill patients to the OT for ST may pose undue and increased risk of complications and death.

Additionally, the suggestion of a reduction in the duration of translaryngeal intubation prior to the procedure when comparing PDT with ST performed in the OT may have several important clinical implications. This shorter waiting period prior to performing the PDT may be due to the ease of organizing the PDT at the bedside, specifically forgoing the need for a surgical consultation and the scheduling of time in often busy OTs. Only two studies \[[@B28],[@B39]\] have examined the time taken from the decision to perform a tracheostomy to the procedure being performed. Both found a significantly shorter time when the tracheostomies were performed using the PDT method. This may have additional implications for critically ill patients, including decreased duration of sedation, earlier weaning from mechanical ventilation and shorter overall length of stay in ICU \[[@B4],[@B47]-[@B49]\].

While long-term complications appear uncommon, the incomplete follow-up and lack of consistent definitions of outcome measurements in the available RCTs make conclusions difficult to draw with certainty. Non-randomized studies that have examined this issue have found that clinically relevant tracheal stenosis was uncommon in PDT when performed by experienced operators in a long-term study of 326 patients \[[@B50]\]. This experience is not universal \[[@B51],[@B52]\], and further investigation to determine how the method and timing of tracheostomy affects long-term outcomes is warranted.

Several clinical trials have compared the various methods of performing PDT, without any method being shown to be conclusively superior \[[@B53]-[@B56]\]. As the majority of studies included in this review used the multiple dilator technique, it is not surprising the results failed to demonstrate any particular benefit from one specific technique of PDT. While it has been suggested that the use of a bronchoscope to guide the operators performing the PDT makes the procedure safer \[[@B57]\], this was not supported by results of our analysis.

There are a number of potential limitations of our review that warrant discussion. Firstly, when considering the above findings, it is important to remember that several groups of patients were excluded from these RCTs, therefore limiting the generalizability of the results of this meta-analysis to all adult critically ill populations. Critically ill patients requiring emergency tracheostomy or with evidence or suspicion of difficult anatomy, prior airway problems, coagulopathies and previous tracheostomy were generally excluded. Thus, ST may still be indicated for selected patients, despite the continuing broader indications for use of PDT \[[@B58]\]. Secondly, while the role of the experience of the operators performing the procedures was presented in Table [1](#T1){ref-type="table"}, the effect that the experience of the operators had on the outcomes could not be formally quantitatively assessed in this analysis. Thirdly, there was considerable heterogeneity in the definitions used across studies for the primary outcomes, in particular wound infection and bleeding. We have attempted to compensate for this by only reporting those episodes of wound infection, bleeding or other complications with obvious clinical relevance, requiring an intervention or that resulted in an alteration to patient management. Fourthly, the validity of our conclusions is, in part, dependent upon the validity of the primary RCTs included. Clearly, the practice of blinding is difficult to perform in surgical trials and it may not be possible to completely blind the adjudication of short-term outcomes. One method to partly address this problem is by setting *a priori*definitions for primary outcomes, as was done in some of the RCTs included in this review. In contrast, study design to maintain allocation concealment was conducted or reported in less than half of the reviewed RCTs. Interestingly, however, those RCTs that reported allocation concealment produced results similar to the overall pooled effect estimates. This may suggest that the conclusions of this meta-analysis are relatively robust to the influence of selected study quality factors. Finally, while there was no evidence of potential bias by inspection of the funnel plots, making significant publication bias unlikely, it is possible that studies were not identified for this review that could have had an impact on the pooled effect estimates.

Several important questions remain to be addressed regarding the use of tracheostomies in critically ill patients. While there is divided opinion as to the optimal timing of tracheostomy, there is as yet little definitive evidence to guide clinicians \[[@B4]\]. Similarly, there is a paucity of definitive evidence demonstrating that one technique of PDT is clearly superior to any other. Finally, the feasibility of determining whether any technique of performing a tracheostomy in critically ill patients is superior with regards to long term outcomes must be questionable given the difficulties in obtaining a large enough cohort and adequate follow up to address this issue.

Conclusion
==========

We have demonstrated that use of PDT is associated with a reduced incidence of wound infection compared to ST in critically ill patients. PDT may yield an overall decreased risk of death when compared with ST. While PDT appears equivalent to ST for the overall incidence of clinically relevant bleeding, major peri-procedural and long term complications, subgroup analysis has revealed that PDT was superior to ST when the ST was performed in the OT. These results indicate that PDT, performed electively in the ICU, should be the method of choice for performing tracheostomies in critically ill adult patients.

Key messages
============

• PDT is associated with a significantly reduced odds of wound infection compared to ST in critically ill patients.

• There was no evidence that PDT was associated with an overall increase in the rate of bleeding, other major complications or long-term complications, compared to ST.

• When compared to ST performed in the operating theatres, PDT is associated with a reduced incidence of bleeding, mortality and a trend towards shorter duration of translaryngeal intubation prior to the tracheostomy being performed.

• The PDT technique, performed in the ICU, should be considered the technique of choice for critically ill patients who require a tracheostomy.
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![Quorum flow diagram summarizing trial flow and reasons for exclusion of studies. PDT, percutaneous dilatational tracheostomy; RCT, randomized clinical trial.](cc4887-1){#F1}

![Forest plot showing the effect of percutaneous dilatational tracheostomy (PDT) compared to surgical tracheostomy (ST) on the incidence of wound infection.](cc4887-2){#F2}

![Forest plot showing the effect of percutaneous dilatational tracheostomy (PDT) compared to surgical tracheostomy (ST) on the incidence of significant bleeding.](cc4887-3){#F3}

![Forest plot showing the effect of percutaneous dilatational tracheostomy (PDT) compared to surgical tracheostomy (ST) on mortality.](cc4887-4){#F4}

###### 

Characteristics of randomized clinical trials comparing percutaneous dilatational and surgical tracheostomy in critically ill patients

  Study              No. of Participants   Mean age (years)   Male (%)   Population             Method of PDT      Location ST performed   Location PDT performed   ST performed by   PDT performed by   Use of bronchoscopic guidance for PDT
  ------------------ --------------------- ------------------ ---------- ---------------------- ------------------ ----------------------- ------------------------ ----------------- ------------------ ---------------------------------------
  Hazard \[30\]      46                    63.1               54.3       Medical/surgical ICU   Multiple dilator   ICU or OT               ICU                      Staff             Trainee            No
  Crofts \[26\]      53                    59.3               58.5       Medical/surgical ICU   Multiple dilator   OT                      ICU                      Trainee           Trainee            No
  Friedman \[28\]    53                    54.5               58.5       Medical/surgical ICU   Multiple dilator   OT                      ICU                      Staff             Trainee            No
  Holdgaard \[32\]   60                    60                 76.7       Medical/surgical ICU   Multiple dilator   OT                      OR                       Trainee           Staff              No
  Jong Joon \[21\]   38                    61                 71         Medical ICU            Multiple dilator   ICU                     ICU                      Trainee           Trainee            Yes
  Gysin \[29\]       70                    55.5               NR         Medical/surgical ICU   Multiple dilator   ICU or OT               ICU or OT                Staff             Staff              Yes
  Porter \[34\]      24                    44.8               79.2       Surgical ICU           Multiple dilator   ICU                     ICU                      Trainee           Trainee            Yes
  Raine \[35\]       100                   43.1               66         Medical/surgical ICU   Forceps            ICU                     ICU                      Staff             Staff              No
  Heikkinen \[31\]   57                    64.6               70.2       Medical/surgical ICU   Forceps            ICU                     ICU                      Staff             Staff              No
  Freeman \[27\]     80                    63.4               46.3       Medical/surgical ICU   Multiple dilator   OT                      ICU                      NR                NR                 Yes
  Massick \[40\]     100                   NR                 NR         Medical/surgical ICU   Multiple dilator   ICU                     ICU                      Trainee           Trainee            Yes
  Melloni \[33\]     50                    56.5               62         Medical/surgical ICU   Multiple dilator   ICU or OT               ICU                      Staff             Staff              Yes
  Sustic \[36\]      16                    36                 81.3       Neurosurgical ICU      Forceps            OT                      ICU                      Staff             Staff              No
  Wu \[38\]          83                    68.8               78.3       Medical/surgical ICU   Multiple dilator   OT                      ICU                      Trainee           Staff              Yes
  Antonelli \[25\]   139                   63.5               59.7       Medical/surgical ICU   Translaryngeal     OT                      ICU                      Staff             Staff              No
  Tabaee \[37\]      43                    60.1               39.5       Medical/surgical ICU   Single dilator     ICU                     ICU                      Trainee           Trainee            Yes
  Silvester \[39\]   200                   60.7               68.5       Medical/surgical ICU   Multiple dilator   ICU                     ICU                      Trainee           Trainee            Yes

ICU, intensive care unit; NR, not reported; OT, operating theatre; PDT, percutaneous dilatational tracheostomy; ST, surgical tracheostomy.

###### 

Summary of validity assessments for RCTs comparing percutaneous dilatational and surgical tracheostomy in critically ill patients

  Study              Allocation concealment   Blinding   Intention-to-treat analysis   Predefined outcomes   Baseline Imbalance
  ------------------ ------------------------ ---------- ----------------------------- --------------------- --------------------
  Hazard \[30\]      No                       No         Yes                           Yes                   No
  Crofts \[26\]      No                       No         Yes                           Yes                   No
  Friedman \[28\]    No                       No         Yes                           Yes                   No
  Holdgaard \[32\]   Yes                      No         Yes                           Yes                   No
  Jong Joon \[21\]   No                       No         Yes                           No                    No
  Gysin \[29\]       No                       Yes        Yes                           Yes                   No
  Porter \[34\]      Yes                      No         Yes                           Yes                   No
  Raine \[35\]       Yes                      No         Yes                           No                    Yes
  Heikkinen \[31\]   No                       No         Yes                           No                    No
  Freeman \[27\]     Yes                      No         Yes                           Yes                   No
  Massick \[40\]     Yes                      No         Yes                           Yes                   No
  Melloni \[33\]     No                       No         Yes                           Yes                   No
  Sustic \[36\]      No                       No         Yes                           Yes                   No
  Wu \[38\]          No                       No         No                            Yes                   No
  Antonelli \[25\]   Yes                      No         Yes                           Yes                   No
  Tabaee \[37\]      No                       No         Yes                           Yes                   No
  Silvester \[39\]   Yes                      Yes        Yes                           Yes                   No

ICU, intensive care unit; NR, not reported; OT, operating theatre; PDT, percutaneous dilatational tracheostomy; ST, surgical tracheostomy.

###### 

Summary of long-term complications comparing percutaneous dilatational and surgical tracheostomy in critically ill patients

  Study              Proportion available for long-term follow-up (%)   Duration of follow-up   Reported complications                                                
  ------------------ -------------------------------------------------- ----------------------- ------------------------ ---------------------------------- --------- ---------
                     ST                                                 PDT                                              Complication                       ST (%)    PDT (%)
                                                                                                                                                                      
  Hazard \[30\]      8/24 (33)                                          11/22 (50)              1.5--3 months            Delayed closure                    3 (38)    0 (0)
                                                                                                                         Tracheal stenosis                  5 (63)    2 (18)
                                                                                                                         Cosmetic deformity                 2 (25)    1 (9)
  Gysin \[29\]       20/35 (57)                                         10/35 (29)              3 months                 Delayed closure                    2 (10)    1 (10)
                                                                                                                         Tracheal cartilage lesion          1 (5)     0 (0)
                                                                                                                         Unesthetic scar                    8 (40)    2 (20)
  Raine \[35\]       26/50 (52)                                         24/50 (48)              4 months                 Tracheal stenosis                  11 (46)   7 (27)
                                                                                                                         Scar requiring surgical revision   5 (21)    2 (8)
  Heikkinen \[31\]   11/56 (20)                                         11/56 (20)              18 months                Delayed closure                    1         0
                                                                                                                         Airway symptoms^a^                 2         2
                                                                                                                         Dysphagia                          1         0
  Wu \[38\]          12/42 (29)                                         15/41 (37)              2--4 years               Tracheal malacia                   1 (8)     0 (0)
  Melloni \[33\]     13/25 (52)                                         15/25 (60)              6 months                 Tracheal malacia                   0 (0)     1 (7)
                                                                                                                         Tracheal stenosis                  0 (0)     1 (7)
  Antonelli \[25\]   13/72 (18)                                         18/67 (27)              12 months                Delayed closure                    7 (54)    7 (39)
                                                                                                                         Airway symptoms^a^                 6 (46)    5 (28)
                                                                                                                         Tracheal stenosis                  2 (11)    1 (6)
                                                                                                                         Need for stomaplasty               3 (16)    1 (6)
  Silvester \[39\]   42/100 (42)                                        29/100 (29)             20 months                Airway symptoms^a^                 10 (24)   12 (41)
                                                                                                                         Stridor                            2 (5)     0 (0)
                                                                                                                         Vocal cord paralysis               1 (2)     0 (0)
                                                                                                                         Unesthetic scar                    2 (5)     0 (0)

^a^Airway symptoms included hoarseness, feeling of a lump in the throat, cough, dyspnea, or subjective phonetic or respiratory problems. PDT, percutaneous dilatational tracheostomy; ST, surgical tracheostomy.

###### 

Sensitivity analysis for primary outcomes comparing percutaneous dilatational and surgical tracheostomy in critically ill patients

  Outcome     Subgroup                      No. of studies   Estimate of OR   95% CI        Test for between subgroup heterogeneity
  ----------- ----------------------------- ---------------- ---------------- ------------- -----------------------------------------
  Infection   Allocation concealment                                                        *P*= 0.65
              Yes                           4                0.33             0.14--0.77    
              No                            7                0.24             0.11--0.53    
              Method of PDT                                                                 *P*= 0.62
              Multiple dilator              9                0.24             0.13--0.47    
              Forceps                       1                0.15             0.01--3.74    
              Translaryngeal                1                0.55             0.15--2.1     
              ST performed                                                                  *P*= 0.70
              ICU                           2                0.49             0.12--1.99    
              OT                            9                0.25             0.13--0.47    
              Use of Bronchoscope for PDT                                                   *P*= 0.28
              Yes                           5                0.40             0.18--0.89    
              No                            6                0.20             0.09--0.46    
                                                                                            
  Bleeding    Allocation concealment                                                        *P*= 0.67
              Yes                           5                0.85             0.46--1.41    
              No                            5                0.71             0.26--1.94    
              Method of PDT                                                                 *P*= 0.33
              Multiple dilator              7                0.96             0.51--1.83    
              Forceps                       1                1.7              0.15--20.17   
              Translaryngeal                1                0.08             0.004--1.37   
              Single dilator                1                1.5              0.06--39.24   
              ST performed                                                                  *P*= 0.009
              ICU                           4                2.01             0.86--4.69    
              OT                            6                0.29             0.12--0.75    
              Use of bronchoscope for PDT                                                   *P*= 0.08
              Yes                           5                1.36             0.65--2.84    
              No                            5                0.34             0.12--0.92    
                                                                                            
  Mortality   Allocation concealment                                                        *P*= 0.86
              Yes                           5                0.81             0.54--1.22    
              No                            7                0.77             0.50--1.19    
              Method of PDT                                                                 *P*= 0.94
              Multiple dilator              9                0.80             0.57--1.11    
              Forceps                       2                0.63             0.16--2.45    
              Translaryngeal                1                0.84             0.40--1.79    
              ST performed                                                                  *P*= 0.2
              ICU                           3                1.09             0.61--1.97    
              OT                            9                0.79             0.50--1.00    
              Use of bronchoscope for PDT                                                   *P*= 0.52
              Yes                           6                0.86             0.58--1.28    
              No                            6                0.71             0.45--1.12    

ICU, intensive care unit; OT, operating theatre; PDT, percutaneous dilatational tracheostomy; ST, surgical tracheostomy.
